-
Published 10/7/2026
Goddard-Eckrich D, Chahine RA, Chandler R, Villani J, Gilbert L, Salsberry P, Dsouza N, Choi S, Walsh SL, Lancaster KE, Oga E, Mack N, D'Costa L, Chatterjee A, Walley AY, Lea CH, Kim E, Calver K, Huang TT, Hunt T, Mack S, Brown JL, David JL, Ezell J, Freisthler B, LaRochelle M, Lyons MS, Mack A, Slavova S, Mack SR, El-Bassel N, Dasgupta A, Pavelka C, Feaster DJ. Differences in trajectories of fatal and nonfatal opioid overdose by race and ethnicity in the HEALing Communities Study from 2018 to 2023. J Subst Use Addict Treat. 2026 Oct 07; 210127. PMID: 42843524.
-
Published 7/1/2026
Hsu HE, Lodi S, Yan S, Bovell-Ammon BJ, Christine PJ, Tilhou AS, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment. JAMA Netw Open. 2026 Jul 01; 9(7):e2623280. PMID: 42446876.
-
Published 7/1/2026
Hall LC, Donohue JM, LaRochelle M, Rossom RC, Wang X, Afshar M, Gellad WF, Groenwold RHH, Han B, Jones CM, Lo-Ciganic WH, Lodi S, Marshall BDL, McLeman BM, Lambert-Harris CA, Saunders EC, Marsch LA. Methodological innovations to advance substance use disorder research: Proceedings of a NIDA workshop on target trial emulation and translational testing of digital health tools. J Subst Use Addict Treat. 2026 Nov; 190:210065. PMID: 42385937.
-
Published 6/23/2026
Adams RS, Reif S, Mohamed Y, Stewart MT, LaRochelle MR, Heaphy D, Corrigan JD, Khorassani FS, Morgan JR. Alcohol use disorder diagnoses among commercially insured US adults from 2016 to 2023, by disability status and sex. Drug Alcohol Depend Rep. 2026 Sep; 20:100461. PMID: 42440433.
-
Published 6/12/2026
Walley AY, Cheng DM, Vandergrift N, Larochelle M, Holloway J, Brown JL, Chandler R, Fanucchi LC, Feaster DJ, Freeman PR, Hunt T, Lofwall MR, Knudsen HK, Nunes EV, Oga E, Oyler DR, Samet JH, Villani J, Walsh SL, Winhusen TJ. The association between naloxone distribution, buprenorphine treatment and retention and incident high-risk opioid prescribing with opioid overdose death in Kentucky, Massachusetts, New York and Ohio, United States: An exploratory community-level cohort study of data from the HEALing Communities Study. Addiction. 2026 Sep; 121(9):2482-2493. PMID: 42283399.